Xolair 150 MG/ML 1S
Ended Awarded Last action
- Contract number
- SPE2DR26FBTHT
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,727
Award facts
- Contract value 100% obligated
- $15,726.96 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,726.96 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 150 mg/ml. The award, issued on January 21, 2026, is structured as a firm fixed-price delivery order with no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This delivery order falls under DMS Pharmaceutical Group's broader Indefinite Delivery Contract (IDC) with the DLA, specifically the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was established as a $30.3 billion acquisition strategy to support Department of Defense pharmaceutical supply needs globally.
DMS Pharmaceutical Group serves as a critical regional prime vendor contractor within the PPV-G GEN V framework, authorized to supply a comprehensive range of pharmaceutical products including branded and generic prescription medications, biologics, and medical consumables to military healthcare facilities worldwide. The company's IDC, valued at $499,999,999 with an ultimate completion date of December 31, 2036, provides a structured procurement vehicle enabling the DLA to issue firm fixed-price delivery orders such as this Xolair supply order to fulfill recurring medical supply requirements across the federal military medical system. The contractor's established performance on numerous delivery orders demonstrates its capability to meet the diverse and specialized pharmaceutical requirements of Department of Defense healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FBTHT?
SPE2DR26FBTHT was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26FBTHT worth?
The government has obligated $15,727 on SPE2DR26FBTHT.
Is contract SPE2DR26FBTHT an order under another contract?
Yes. SPE2DR26FBTHT is a delivery order under SPE2DR25D9628, an indefinite delivery contract.
Was contract SPE2DR26FBTHT competed?
The extent of competition for SPE2DR26FBTHT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award